Meloxicam (15 mg) does not interfere with the antiplatelet effect of aspirin in healthy volunteers

被引：0
|
作者：
van Ryn, J
Kink-Eiband, M
Kuritsch, I
Feifel, U
Hanft, G
Wallenstein, G
Trummlitz, G
机构：
[1] Boehringer Ingelheim KG, Drug Discovery Support, Biberach, Germany
[2] Boehringer Ingelheim KG, Clin Res, Biberach, Germany
[3] Boehringer Ingelheim KG, Med Data Serv, Biberach, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：143 / 143
页数：1
相关论文
共 50 条
  • [21] EFFECT OF ASPIRIN ON FECAL BLOOD LOSS WITH GASTROSCOPIC CORRELATION IN HEALTHY VOLUNTEERS
    KUIPER, DH
    FALL, DJ
    OVERHOLT, BF
    POLLARD, HM
    ANNALS OF INTERNAL MEDICINE, 1969, 70 (05) : 1069 - +
  • [22] A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers
    Patoia, L
    Santucci, L
    Furno, P
    Dionisi, MS
    DellOrso, S
    Romagnoli, M
    Sattarinia, A
    Marini, MG
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 : 61 - 67
  • [23] Effect of omeprazole on the bioavailability of aspirin: A randomized controlled study on healthy volunteers.
    Anand, BS
    Sanduja, SK
    Lichtenberger, LM
    GASTROENTEROLOGY, 1999, 116 (04) : A371 - A371
  • [24] EFFECT OF FOOD ON THE BIOAVAILABILITY OF PALBOCICLIB 125 MG CAPSULES IN HEALTHY VOLUNTEERS
    Ruiz-Garcia, A.
    Plotka, A.
    Pawlak, S.
    O'Gorman, M.
    Kosa, M.
    Nidadavolu, S.
    Phillips, S.
    Wang, D. D.
    ANNALS OF ONCOLOGY, 2014, 25
  • [25] Does the timing of aspirin administration influence its antiplatelet effect - review of literature on chronotherapy
    Miciak-Lawicka, Ewa
    Begier-Krasinska, Beata
    Tykarski, Andrzej
    Krasinski, Zbigniew
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA-POLISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 15 (02) : 125 - 129
  • [26] NO EFFECT OF ASPIRIN ON BETA-THROMBOGLOBULIN PLASMA-LEVELS IN HEALTHY-VOLUNTEERS
    HOOGENDIJK, EMG
    TENCATE, JW
    LUDLAM, CA
    BRUIN, T
    THROMBOSIS RESEARCH, 1980, 19 (1-2) : 257 - 262
  • [27] Lumiracoxib does not affect the ex vivo antiplatelet aggregation activity of low-dose aspirin in healthy subjects
    Jermany, J
    Branson, J
    Schmouder, R
    Guillaume, M
    Rordorf, C
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (10): : 1172 - 1178
  • [28] Development of reference methods for evaluating the effect of aspirin and for comparison with routinely used methods; the lack of aspirin resistance in healthy volunteers
    Katona, E.
    Kovacs, E. G.
    Bereczky, Z.
    Balogh, L.
    Homorodi, N.
    Haramura, G.
    Toth, E.
    Csapo, J.
    Edes, I
    Muszbek, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 15 - 16
  • [29] Statin therapy has an antiplatelet effect and does not interfere with the loading dose of clopidogrel in patients with ischaemic heart disease
    Zsamboki, E. Toth
    Beres, B. J.
    Vargova, K.
    Fischer, E.
    Csoti, E.
    Kerecsen, G.
    Preda, I.
    Kiss, R. G.
    EUROPEAN HEART JOURNAL, 2005, 26 : 485 - 486
  • [30] Is there an ideal way to initiate antiplatelet therapy with aspirin? A crossover study on healthy volunteers evaluating different dosing schemes with whole blood aggregometry
    Meves S.H.
    Neubauer H.
    Overbeck U.
    Endres H.G.
    BMC Research Notes, 4 (1)
12345